All In Biotech

Drug Trial Radar · NCT06972056

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 1,335 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,335

Planned (sponsor's estimate)

Start

Jul 9, 2025

Primary completion

Mar 1, 2029

Study completion Dec 1, 2029

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Iowa; Patient-Centered Outcomes Research Institute; AbbVie
First posted
May 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerable than the others. Research participants will: * Be randomly assigned to one of the three medications. * Provide information about their migraine pattern using a daily headache diary and during research visits.

Conditions

  • Migraine

Interventions

  • Atogepant 60 mgDrug

    Atogepant at a dose up to 60 mg daily.

  • Propranolol 160 mgDrug

    Daily propranolol up to 80 mg twice daily.

  • Topiramate 100 mgDrug

    Daily topiramate, up to 50 mg twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment Responder (atogepant vs. topiramate; atogepant vs. propranolol)Time frame: Weeks 9-12 post-randomization compared to the 4 weeks prior to randomization

Locations

39 sites in 1 country. Site status is shown where the registry gives one.

  • Apogee Clinical Research

    Hazel Green, Alabama · Not yet recruiting

  • Northern Arizona Healthcare

    Flagstaff, Arizona · Recruiting

  • Mayo Clinic Arizona

    Phoenix, Arizona · Recruiting

  • Keck School of Medicine of USC

    Los Angeles, California · Recruiting

  • Clinical Research Institute

    Los Angeles, California · Recruiting

  • Desert Physicians Medical Group

    Palm Springs, California · Recruiting

  • The Neurology Group

    Pomona, California · Recruiting

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado · Recruiting

  • Memorial Healthcare

    Hollywood, Florida · Recruiting

  • Mayo Clinic Florida

    Jacksonville, Florida · Recruiting

  • Apple Med Research

    Miami, Florida · Recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • Indiana University

    Indianapolis, Indiana · Not yet recruiting

  • Neuroscience Research Center

    Overland Park, Kansas · Recruiting

  • Clinical Trials of New England

    Hyde Park, Massachusetts · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Washington University St Louis

    St Louis, Missouri · Recruiting

  • Nebraska Medical Center

    Omaha, Nebraska · Recruiting

  • Advanced Research Institute Reno

    Reno, Nevada · Recruiting

  • JFK Neuroscience Institute

    Edison, New Jersey · Recruiting

  • Nuvance Health Institute

    Kingston, New York · Recruiting

  • Northwell Health

    Manhasset, New York · Recruiting

  • Mt Sinai Icahn School of Medicine

    New York, New York · Recruiting

  • Onsite Clinical Solutions Park Cedar Dr.

    Charlotte, North Carolina · Recruiting

  • Onsite Clinical Solutions Mecklenburg

    Charlotte, North Carolina · Recruiting

  • Onsite Clinical Solutions Ballantyne

    Charlotte, North Carolina · Recruiting

  • Onsite Clinical Solutions Salisbury

    Salisbury, North Carolina · Recruiting

  • Wake Forest University Health

    Winston-Salem, North Carolina · Recruiting

  • Ohio State University Wexner Medical Center

    Columbus, Ohio · Recruiting

  • Advanced Research Institute

    Portland, Oregon · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • Brown University Health

    Providence, Rhode Island · Recruiting

  • Vanderbilt Medical Center

    Nashville, Tennessee · Recruiting

  • DHR Health Headache Center

    McAllen, Texas · Recruiting

  • Advanced Research Institute Ogden

    Ogden, Utah · Recruiting

  • University of Vermont Medical Center

    Burlington, Vermont · Not yet recruiting

  • West Virginia University

    Morgantown, West Virginia · Recruiting

  • Marshfield Clinic Research Institute

    Marshfield, Wisconsin · Recruiting

  • The Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.